Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
Follow your healthcare provider's recommendations regarding hydration and nutrition
In 2023, the FDA expanded Wegovy approval to include adolescents 12 years and older, but only under specific circumstances and with careful clinical oversight
As a real-world analysis, the study carries important caveats
Phase 3: TRANSCEND-T2D-1 Results (May 2026) In May 2026, Eli Lilly released topline results from TRANSCEND-T2D-1, the first Phase 3 trial for retatrutide in adults with type 2 diabetes
US$ 25.79
US$ 28.60
US$ 24.35
US$ 20.97
US$ 20.82
US$ 27.88
US$ 20.13
